ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Utilization of Liver Allografts from Deceased Donors. Non Medical Causes for Discard. A Review of the SRTR Annual Report

    M. Asolati,1 C. Kulig,2 B. Bilir,2 T. Pillen,1 P. Gauthier,2 B. Bista,2 T. Heffron.1

    1Surgery, Porter Adventist Hospital, Denver, CO; 2Medicine, Porter Adventist Hospital, Denver, CO.

    INTRODUCTION: Discrepancy between demand (end stage organ disease) and supply (organs) remains one of the limiting factors in solid organ transplantation and underlies the dynamics…
  • 2015 American Transplant Congress

    Vitamin D Deficiency in Liver Transplant Recipients: Prevalence, Risk Factors, and Outcomes

    T. Joson, T. Schiano, A. Mehrotra.

    Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.

    Vitamin D is known to be immunomodulatory, and its deficiency is associated with multiple chronic health problems in the general population. The objective of this…
  • 2015 American Transplant Congress

    Age Should Not Be Considered a Contraindication for Living Kidney Donation

    D.-A. Moutzouris, R. Charif, J. Galliford, J. McDermott, H. Dulku, H. Orr, D. Taube, M. Loucaidou.

    Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.

    The increasing numbers of patients with ESRD on the transplant waiting list has been the main driving force for expanding the donor pool. Acceptance of…
  • 2015 American Transplant Congress

    The Effect of Changing Candidate Demographics on Living Donor Kidney Transplant Rates

    G. Vranic, A. Nishio Lucar, D. Keith.

    Medicine, University of Virginia, Charlottesville, VA.

    Living donor (LD) rates continue to decline despite a growing list of candidates for renal transplant in the US. While there are many factors driving…
  • 2015 American Transplant Congress

    The Impact of Center Volume on Simultaneous Kidney-Pancreas Transplantation Outcomes

    A. Malone,1 D. Brennan,1 J. Wellen,2 T. Alhamad.1

    1Transplantation Nephrology, Renal Division, Washington University, St Louis; 2Section of Transplant Surgery, Washington University, St Louis.

    Background: Pancreas transplantation is associated with a high incidence of surgical complications and successful outcomes require experienced surgical and post-transplant care. Prior studies have linked…
  • 2015 American Transplant Congress

    Do Induction Therapy, Patient-Level and Post-Operative Factors Impact Outcomes in Moderate to High Immunologic Risk Simultaneous Kidney-Pancreas Transplantation in the Era of Stringent HLA Cross-Matching?

    V. Rohan, D. Taber, D. Taraskiewicz, S. Nadig, J. Mcgillicuddy, K. Chavin, P. Baliga, C. Bratton.

    MUSC, Charleston, SC.

    Background: Simultaneous kidney and pancreas transplantation (SPK) is a lifesaving procedure for patients with diabetes mellitus. The success of SPK is dependent upon minimization of…
  • 2015 American Transplant Congress

    Medication Adherence and Treatment Satisfaction in Liver Transplant Recipients

    A. Albekairy,1 A. Alkatheri,2 N. Khalidi,2 K. Thiab,1 A. Jarab,2 A. Qandil,3 A. Alshaya,2 K. BinSaleh.2

    1Pharmaceutical Care Department, King Abdulaziz Medical City-NGHA, Riyadh, Saudi Arabia; 2Pharmacy Practice, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 3Pharmaceutical Sciences, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

    Background: Research has indicated that adherence to medication in patients with liver transplant is poor and considered as one of the main barriers to the…
  • 2015 American Transplant Congress

    Metabolomic Analysis of Remote Ischemic Preconditioning in Renal Ischemia Reperfusion Injury

    A. Han,1 S.-I. Min,1 K. Cho,2 C. Choi,1 S.-K. Min,1 S. Kim,3 M. Park,4 J.-Y. Cho,2 J. Ha.1

    1Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea; 2Depratment of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine, Seoul, Republic of Korea; 3Depratment of Surgery, Myongji Hospital, Goyang-si, Gyeonggi-do, Republic of Korea; 4Korean Organ Donation Agency, Seoul, Republic of Korea.

    Background. Ischemic reperfusion injury (IRI), an inevitable process during kidney transplantation, can cause significant graft damage and may play a role in delayed graft function.…
  • 2015 American Transplant Congress

    Changes in Immunophenotypes After Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplant Recipients

    A. Yildiz,1,4 M. Cavusoğlu,1 S. Adin,2 Y. çaliskan,1 A. Ozkok,1 H. Tasçi,3 G. Deniz,2 M. Sariyar.3

    1Internal Medicine, Nephrology, Istanbul School of Medicine, Istanbul, Turkey; 2Immunology, Experimental Medicine and Research Center, Istanbul, Turkey; 3General Surgery, Medicana Organ Transplant Center, Istanbul, Turkey.

    Chronic toxicity of calcineurin inhibitors (CNI) is one of the major causes of chronic allograft loss. Conversion from CNI to mTOR ((mammalian target of rapamycin)…
  • 2015 American Transplant Congress

    Implication of Intragraft γδ T Cell Profiles in Operational Tolerance After Clinical Transplantation of Highly Immunogenic Intestine -Difference from Immunoprivileged Liver

    Y. Li,1 X. Zhao,1 H. Ohe,2 H. Nafady-Hego,3 A. Bishop,4 J. Pirenne,5 T. Koshiba.6

    1Kyoto University, Kyoto, Japan; 2Matsue Red Cross Hospital, Matsue, Japan; 3Assiut Universty, Assiut, Egypt; 4University of Sydney, Sydney, Australia; 5University of Leuven, Leuven, Belgium; 6Fukushima Medical University, Fukushima, Japan.

    (Background) T-cell receptor (TCR) Vδ2 γ δ T cells (Vδ 2 cells) participate in host defense, whereas Vδ 1 γ δ T cells (Vδ 1…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences